DNA sensors and associated signaling pathways in the innate immune response
先天免疫反应中的 DNA 传感器和相关信号通路
基本信息
- 批准号:8297717
- 负责人:
- 金额:$ 36.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-15 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIM2 geneAdjuvantAffectAutoimmune DiseasesAutoimmune ResponsesAutoimmunityAutomobile DrivingBoxingCaspase-1Cell LineCellsComplexDNADNA VaccinesDNA VirusesDNA-Binding ProteinsDiseaseFamily memberGene Expression RegulationGenesGenetic TranscriptionHerpesviridaeHost DefenseImmuneImmune responseImmune systemImmunityIn VitroInfectionInflammatoryInflammatory ResponseInterferon ActivationInterferon Type IInterferonsInterleukin-1Interleukin-18InvadedKaposi SarcomaKnockout MiceLaboratoriesLeadLigandsMediatingMolecularMusNatural ImmunityNuclearNucleic AcidsOrthologous GenePathogenesisPathologyPathway interactionsPlayProcessProductionProteinsRNARoleSignal PathwaySignal TransductionSystemic Lupus ErythematosusTANK-binding kinase 1TBK1 geneTestingTherapeuticTimeViralVirusVirus DiseasesWorkantimicrobialbasecytokinedesignfightinggene inductionhelicasehuman IRF3 proteinin vivointerferon regulatory factor-3marenostrinmicrobialmicrobial hostnew therapeutic targetnovel therapeuticspathogenpreventreceptorresponsesensorsmall hairpin RNAvaccine efficacyviral DNA
项目摘要
DESCRIPTION (provided by applicant): RNA and DNA elicit inflammatory responses which are critical for anti-microbial immunity. DNA is a potent trigger of inflammatory cytokine and type
I IFN gene transcription, as well as caspase-1-mediated processing of the pro-inflammatory cytokines IL-1? and IL-18. Growing evidence indicates that DNA recognition is central not only to anti-microbial host defenses but is also a major contributor to the adjuvant activity of DNA vaccines as well as the pathology associated with autoimmune diseases such as Systemic Lupus Erythematosis. It is therefore critical that we understand the molecular basis of DNA recognition. Recent work from our group has implicated the PYHIN family members Absent in melanoma-2 (AIM2) and the interferon-inducible protein (IFI16) as sensors of microbial DNA. Both proteins bind DNA via HIN domains. AIM2 engages ASC via a pyrin domain to form a caspase-1 activating inflammasome while IFI16 activates a cytosolic signaling pathway involving Stimulator of IFN genes (STING), TANK binding kinase-1 (TBK-1) and interferon regulatory factor 3 (IRF3) to regulate transcription of type I IFN genes. Knockdown of IFI16, or its murine ortholog p204 prevents viral DNA from triggering IRF3 activation and IFN? gene induction, while not affecting responses to cytosolic RNA. Recent evidence also indicates that IFI16 can form an inflammasome in responses to nuclear sensing of Kaposi's Sarcoma Herpes Virus infection. Additional work from our laboratories has also implicated the DEAD box helicase DEAD box protein 3x (DDX3x) in the TBK1/IRF3 signaling pathway important for both RNA and cytoplasmic DNA pathways (including for IFI16), but its role in innate immunity remains to be fully characterized. The underlying hypothesis to be tested in this proposal is that IFI16 plays a
central role in innate immunity and host-defense to microbial pathogens by regulating inflammatory responses and that DDX3x is an important downstream component of the IFI16 signaling pathway. We propose to explore the molecular mechanisms of IFI16 activation and define the role of IFI16 and DDX3x in anti-viral host-defenses. This project will increase our understanding of how the innate immune system senses pathogens, leading to novel therapeutic targets.
PUBLIC HEALTH RELEVANCE: Cells have immune sensors that detect DNA from invading viruses, giving rise to appropriate protective anti-viral cellular responses controlled by interferons. These responses are at times inappropriately activated by self-DNA, leading to pathological autoimmune responses. We have discovered that a cellular protein called IFI16 is such a sensor, and understanding how it works will lead to therapies to enhance or dampen immune responses to fight pathogens or suppressing autoimmune responses respectively.
描述(由申请人提供):RNA和DNA引起炎症反应,这对抗微生物免疫至关重要。DNA是炎症细胞因子和类型的有力触发器
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine A. Fitzgerald其他文献
Quantifying and Mitigating Motor Phenotypes Induced by Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System Antisense Oligonucleotides in the Central Nervous System
量化和减轻中枢神经系统中反义寡核苷酸诱导的运动表型 量化和减轻中枢神经系统中反义寡核苷酸诱导的运动表型
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Michael P. Moazami;Julia M. Rembetsy;Feng Wang;P. M. Krishnamurthy;Alexandra Weiss;M. Marosfoi;Robert M. King;M. Motwani;H. Gray;Katherine A. Fitzgerald;Robert H Brown;Jonathan K. Watts - 通讯作者:
Jonathan K. Watts
Lipopolysaccharide sensing on the inside
内部的脂多糖感应
- DOI:
10.1038/nature12556 - 发表时间:
2013-09-04 - 期刊:
- 影响因子:48.500
- 作者:
Vijay A. K. Rathinam;Katherine A. Fitzgerald - 通讯作者:
Katherine A. Fitzgerald
α位に種々の置換基を有するジチオアセタール類の選択的電解フッ素化
α位具有各种取代基的二硫缩醛的选择性电氟化
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Sarah M. McWhirter;Roman Barbalat;Kathryn M. Monroe;Mary F. Fontana;Mamoru Hyodo;Nathalie T. Joncker;Ken J. Ishi;Shizuo Akira;Marco Colonna;Zhijian J. Chen;Katherine A. Fitzgerald;Yoshihiro Hayakawa;and Russell E. Vance;小手石泰康・野正樹・山口和也・鈴木晋一郎;両角俊也・尹斌・稲木信介・淵上寿雄 - 通讯作者:
両角俊也・尹斌・稲木信介・淵上寿雄
Long non-coding RNAs: definitions, functions, challenges and recommendations
长链非编码 RNA:定义、功能、挑战与建议
- DOI:
10.1038/s41580-022-00566-8 - 发表时间:
2023-01-03 - 期刊:
- 影响因子:90.200
- 作者:
John S. Mattick;Paulo P. Amaral;Piero Carninci;Susan Carpenter;Howard Y. Chang;Ling-Ling Chen;Runsheng Chen;Caroline Dean;Marcel E. Dinger;Katherine A. Fitzgerald;Thomas R. Gingeras;Mitchell Guttman;Tetsuro Hirose;Maite Huarte;Rory Johnson;Chandrasekhar Kanduri;Philipp Kapranov;Jeanne B. Lawrence;Jeannie T. Lee;Joshua T. Mendell;Timothy R. Mercer;Kathryn J. Moore;Shinichi Nakagawa;John L. Rinn;David L. Spector;Igor Ulitsky;Yue Wan;Jeremy E. Wilusz;Mian Wu - 通讯作者:
Mian Wu
A pan-family screen of nuclear receptors in immunocytes reveals ligand-dependent inflammasome control
- DOI:
10.1016/j.immuni.2024.10.010 - 发表时间:
2024-12-10 - 期刊:
- 影响因子:
- 作者:
Yutao Wang;Yanbo Zhang;Kyungsub Kim;Jichang Han;Daniel Okin;Zhaozhao Jiang;Liang Yang;Arun Subramaniam;Terry K. Means;Frank O. Nestlé;Katherine A. Fitzgerald;Gwendalyn J. Randolph;Cammie F. Lesser;Jonathan C. Kagan;Diane Mathis;Christophe Benoist - 通讯作者:
Christophe Benoist
Katherine A. Fitzgerald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine A. Fitzgerald', 18)}}的其他基金
Radioresistant Innate Immunity in SAVI Tissue-Specific Autoinflammation
SAVI 组织特异性自身炎症中的抗辐射先天免疫
- 批准号:
10752556 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
9th Annual meeting of the International Cytokine and Interferon Society Meeting
国际细胞因子和干扰素学会第九届年会
- 批准号:
10389980 - 财政年份:2021
- 资助金额:
$ 36.52万 - 项目类别:
Training in the Molecular Basis of Autoimmunity and Autoinflammation
自身免疫和自身炎症的分子基础培训
- 批准号:
10201428 - 财政年份:2018
- 资助金额:
$ 36.52万 - 项目类别:
Training in the Molecular Basis of Autoimmunity and Autoinflammation
自身免疫和自身炎症的分子基础培训
- 批准号:
10442502 - 财政年份:2018
- 资助金额:
$ 36.52万 - 项目类别:
Training in the Molecular Basis of Autoimmunity and Autoinflammation
自身免疫和自身炎症的分子基础培训
- 批准号:
10712784 - 财政年份:2018
- 资助金额:
$ 36.52万 - 项目类别:
Regulation of Lupus by Cytosolic DNA Sensors
细胞质 DNA 传感器对狼疮的调节
- 批准号:
9229764 - 财政年份:2017
- 资助金额:
$ 36.52万 - 项目类别:
Characterization of Chromatin associated Long non-coding in immunity
免疫中染色质相关长非编码的表征
- 批准号:
8809301 - 财政年份:2014
- 资助金额:
$ 36.52万 - 项目类别:
Characterization of Chromatin associated Long non-coding in immunity
免疫中染色质相关长非编码的表征
- 批准号:
8966645 - 财政年份:2014
- 资助金额:
$ 36.52万 - 项目类别:
DNA sensors and associated signaling pathways in the innate immune response
先天免疫反应中的 DNA 传感器和相关信号通路
- 批准号:
8606390 - 财政年份:2012
- 资助金额:
$ 36.52万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 36.52万 - 项目类别: